Iron Supplementation to Reduce Preschoolers Anemia: Comparison Between Intermittent and Cyclic Procedure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim: To evaluate the efficacy of iron supplements given at intervals corresponding to the mean life of red blood cells compared to weekly supplementation, in reducing the prevalence of preschool anemia.

Method: Ninety-nine children from public day care centers with ages from 24 to 59 months old were randomly divided into two groups. All the children received 40 doses of 30 mg of ferrous sulfate during a 10-month intervention period. Group 1 received once weekly supplementation and Group 2 received supplementation in two 5-month cycles, each cycle consisting of one month of supplementation (20 workdays) and four months without supplementation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Rice Fortification With Iron on Anemia Among Children

NCT00727545

Iron Deficiency Anemia

COMPLETED PHASE2/PHASE3

Iron-Deficiency Anemia in Infants in Two Weekly Programs

NCT00655408

Anemia

COMPLETED NA

The Use of Ultra Rice Compared to Iron Drops Consumed by Anemic Children

NCT00839761

Anemia Iron Deficiency Anemia

COMPLETED NA

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

NCT06550362

Iron Deficiency Anemia

NOT_YET_RECRUITING PHASE4

Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants

NCT00642863

Iron Deficiency Iron Deficiency Anemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prevalence of anemia after the supplementation regimens reduced from 20.20% to 5.05% (P \< 0.0005); the reduction was not significantly different between the two groups (P = 0.35). The mean hemoglobin concentration increased in both groups (Group 1: 0.27 g/dL; P \< 0.016 and Group 2: 0.47 g/dL; P \< 0.0005) without significant differences between the groups (P = 0.17).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1:iron weekly supplementation

Group Type ACTIVE_COMPARATOR

iron supplementation

Intervention Type DRUG

40 doses of 30 mg of ferrous sulfate during a 10-month intervention period

Group 2: cycle supplementation

two 5-month cycles, each cycle consisting of one month of supplementation (20 workdays) and four months without supplementation.

Group Type ACTIVE_COMPARATOR

iron supplementation

Intervention Type BIOLOGICAL

supplementation in two 5-month cycles, each cycle consisting of one month of supplementation (20 workdays) and four months without supplementation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.